American Journal of Medical and Biological Research
ISSN (Print): 2328-4080 ISSN (Online): 2328-4099 Website: Editor-in-chief: Apply for this position
Open Access
Journal Browser
American Journal of Medical and Biological Research. 2014, 2(6), 121-123
DOI: 10.12691/ajmbr-2-6-1
Open AccessReview Article

Pre Eclampsia and Iron Status: A Review

Sabitha Kandi1, Sudhakar T1, C Ramadevi2, B Venugopal1, Rajkumar1, Md Rafi1 and K V Ramana3,

1Department of Biochemistry, Chalmeda AnandRao Institute of Medical Sciences, Bommakal, Karimnagar, Andhra Pradesh

2Department of Obsterics and Gynaecology, Chalmeda AnandRao Institute of Medical Sciences, Bommakal, Karimnagar, Andhra Pradesh

3Department of Microbiology, Prathima institute of Medical Sciences, Nagnur, Karimnagar, Andhra Pradesh

Pub. Date: December 22, 2014

Cite this paper:
Sabitha Kandi, Sudhakar T, C Ramadevi, B Venugopal, Rajkumar, Md Rafi and K V Ramana. Pre Eclampsia and Iron Status: A Review. American Journal of Medical and Biological Research. 2014; 2(6):121-123. doi: 10.12691/ajmbr-2-6-1


Preeclampsia is an idiopathic multisystem disorder specific to pregnancy and development of hypertension and proteinuria, increased vascular resistance and endothelial dysfunction in the mother , altered placental perfusion and restricted fetal growth. The vasospasm leads to destruction of RBCs release iron thus, there is elevated serum iron levels in preeclamptic women. The excess iron released from destruction of RBCs can react with free radicals produced from cell membrane (as it is rich in polyunsaturated fatty acids) and circulating lipoproteins initiates lipid peroxidation both in placenta and vasculature. This is one of the significant etiologic factors in the endothelial cell damage of preeclampsia. the raised serum iron levels in turn alters the iron related parameters like total iron binding capacity(TIBC), serum ferritin, transferrin, percent saturation.

preeclampsia serum iron levels TIBC transferrin

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Margaret PR, Johj B, Robert WE, Christopher WG. Redman, Laurence JK. Abnormal iron parameters in the pregnancy syndrome preeclampsia. American Journal of Obstetrics and Gynaecology. 2002; 187: 412-418.
[2]  Sabitha, Kandi, et al. "Role of Antioxidant Enzymes in Glucose and Lipid Metabolism in Association with Obesityand Type 2 Diabetes." American Journal of Medical Sciences and Medicine 2.1 (2014): 21-24.
[3]  Trefor F, Ernest B and Basil TD. Hemoglobin, Iron and Bilirubin. In: Tietz textbook of clinical chemistry and molecular diagnostics. Edited by CA Burtis, ER Ashwood, DE Burns. 4Th edition; 1192-1198.
[4]  D C Sharma, Rati Mathur, PP singh. Iron metabolism: A Review. Indian Journal Of Clinical Biochemistry. 1993; 8(2); 80-101.
[5]  Prakash M. Role of non – transferrin – bound iron in chronic renal failure and other disease conditions. Indian Journal Of Nephrology. 2007; 17(4): 188-193.
[6]  Crichton RR, Charloteaux – Wauters M. Iron transport and storage. European Journal of Biochemistry, 1987; 164(3); 485-506.
[7]  Aisen P, Leibman A, Zweier J. Stoichiometric and site characteristics of the binding of iron to human transferrin. Journal of Biological Chemistry. 1978; 253(6):1930-1937.
[8]  Granier T, Langlois d' Estaintot B, Gallois B, Chevalier JM, Precigoux G et al.,. Structural description of the active sites of mouse L – chain Ferritin at 1.2 A resolution. Journal of Biological Inorganic chemistry. 2003; 8(1-2); 105-111.
[9]  Burtis CA, Ashwood ER, Bruns DE. Peptides and protein. Tietz textbook of clinical chemistry and molecular diagnostics. 2006; 556-557.
[10]  Philippe A, Gianazza E and Mischel L. Study of acute phase reactants ceruloplasmin. Methods in enzymology. 1998; 163: 441-452.
[11]  Pamela Bielli, Lilia Calabrese. Structure to function relationships in ceruloplasmin: a 'moon lighting protein. Cellular and Molecular Life sciences. 2002; 59: 1413-1427.
[12]  Mohanty S, Nayak N, Nanda N, Rao P. Serum lipids and malondialdehyde levels in primiparous patients with pregnancy induced hypertension. Indian Journal of Clinical Biochemistry. 2006; 21(1): 189-192.
[13]  Dr. Tasneem Zafar, Dr. Zafar Iqbal. Iron status in pre eclampsia. Journal of professional Medicine. 2008; 15(1): 74-80.
[14]  P. Samuels, EK Main, MT Mennuti, SG Gabbe. The origin of serum iron in pregnancy induced hypertension.American Journal of Obstetrics and Gynaecology. 1987; 157: 721-725.
[15]  N. Vitoratos, E. Salamalekis, N Dalamaga, D Kassanos, G Creatsas. Defective antioxidant mechanisms via changes in serum ceruloplasmin and total iron binding capacty of serum in women with pre eclampsia. European Journal of Obstetrics and Gynaecology & Reproductive Biology. 1999; 84(1): 63-67.
[16]  Hubel CA, Boberts JM, Tayler RN. Lipid peroxidation in pre eclampsia; a new prospectives on pre eclampsia. American journal of Obstetrics and Gynaecology. 1989; 161: 1025-1034.
[17]  Rabadeh T, Parya BF. Relation between S. Ferritin and iron parameters with preeclampsia. Journal of Family and Reproductive Health. 2007; 1(2): 87-91.
[18]  Ganiyu A, Ayo A, Ayodele B, Adijat A, Adebayo A. Serum concentrations of imunoglobulins and acute phase proteins in Nigerian women with preecampsia. Reproductive Biology 2006; 6(3): 265-274.
[19]  CA Hubel, AV Kozlov, VE Kagan. Decreased transferrin and increased transferrin saturation in sera of women with preeclampsia: Implications for oxidative stress. American Journal of Obstetrics Gynaecology. 1996; 175: 692-700.
[20]  P. Samuels, EK Main, MT Mennuti, SG Gabbe. The origin of serum iron in pregnancy induced hypertension. American Journal of Obstetrics Gynecology. 1987; 157: 721-725.
[21]  Hubel CA. Dyslipidemia, iron and oxidative stress in preeclampsia: assessment of maternal and feto-placental interactions. Seminar Reproduction Endocrinology. 1998; 16: 75-92.
[22]  CA Hubel, Lm Bodnar, G Harger, RB Ness, JM Roberts. Nonglycosylated ferritin predominates in the circulation of women with preeclampsia but nor intrauterine growth restriction. Clinical Chemistry. 2004;50(5): 948-951.
[23]  L – Shakour – Shahabi, S. Abbasali – Zadeh and N. Rashtchi – zadeh. Serum level and antioxidant activity of ceruloplasmin in preeclampsia. Pakistan Journal of Biological science. 2010; 13(13): 621-627.
[24]  Titantin K, Tamar S, Rusudan K. Alterations of oxidative metabolism at the pregnancy attended with preeclampsia. Tbilisi State Medical Unversity. 2004; 4(1): 34-36.
[25]  Shalini Gupta, Smiti Nanda, Uma Singh, Sadhana Bansal and Harbans Lal. Evaluation of the changes in serum iron levels in preeclampsia. Indian Journal of Clinical Biochemistry. 1997; 12(1): 91-94.